Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$0.07.

  • Eton Pharmaceuticals' EPS (Basic) fell 45000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.26, marking a year-over-year decrease of 1818.18%. This contributed to the annual value of -$0.15 for FY2024, which is 26908.55% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its EPS (Basic) stood at -$0.07 for Q3 2025, which was down 45000.0% from -$0.1 recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' EPS (Basic) ranged from a high of $0.21 in Q1 2021 and a low of -$210.0 during Q1 2022
  • Over the past 5 years, Eton Pharmaceuticals' median EPS (Basic) value was -$0.06 (recorded in 2022), while the average stood at -$11.09.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 10010000.0% in 2022, then surged by 39028.75% in 2023.
  • Over the past 5 years, Eton Pharmaceuticals' EPS (Basic) (Quarter) stood at $0.04 in 2021, then fell by 2.96% to $0.04 in 2022, then plummeted by 325.0% to -$0.09 in 2023, then surged by 74.34% to -$0.02 in 2024, then tumbled by 203.12% to -$0.07 in 2025.
  • Its last three reported values are -$0.07 in Q3 2025, -$0.1 for Q2 2025, and -$0.06 during Q1 2025.